Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W

Slides:

Advertisements

Similar presentations

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Advertisements

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Yang Liu, MD,

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Amit Mathur, MD, Maher Baz, MD, E

Minimally Invasive Extracorporeal Bypass in Minimally Invasive Heart Valve Operations: A Prospective Randomized Trial Hardy Baumbach, MD, Christian J.

Andrew D. Shaw, MB, Ara A. Vaporciyan, MD, Xifeng Wu, MD, Terri M

Total Arch Replacement Under Normothermic Beating Heart Surgery

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report John S. Ikonomidis, MD, PhD The Annals of Thoracic.

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Burdens Without Blessings: Peer Reviewers Get No Respect

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Robotic-Assisted Coronary Artery Bypass on a Beating Heart: Initial Experience and Implications for the Future William F. Turner, MD, John H. Sloan,

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Simvastatin Increases Neutrophil Apoptosis and Reduces Inflammatory Reaction After Coronary Surgery Massimo Chello, MD, Amedeo Anselmi, MD, Cristiano.

Zheng-Zhe Feng, MD, Jian Shi, MD, Xue-Wei Zhao, MD, Zhi-Fei Xu, MD

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Pleural Metastasis of Osteosarcoma

William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E

Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.

Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Martin Strüber, MD, Jochen T Cremer, MD, Bernhard.

Uncoupling of Myocardial β-Adrenergic Receptor Signaling During Coronary Artery Bypass Grafting: The Role of GRK2 Christian F. Bulcao, MD, Prakash K.

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Who Do You Say You Are? The Annals of Thoracic Surgery

Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation Kyrylo.

Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation Benjamin Hippen, MD, Lainie.

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial Gavin J Murphy, MD, FRCS,

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

An Unusual Cause of Hemoptysis in a Young Woman

A. Thomas Pezzella, MD, Sari D

The Annals of Thoracic Surgery

Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Rotational Thromboelastometry Predicts Increased Bleeding After Off-Pump Coronary Bypass Surgery Sarah Soh, MD, Young-Lan Kwak, MD, PhD, Jong-Wook Song,

Acute Esophageal Necrosis: A Case Series and Long-Term Follow-Up

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery Reza Motallebzadeh, MRCS, J.

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis Richard.

Robert Lee Replogle, September 30, 1931–May 9, 2016

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

The American Board of Thoracic Surgery: Update

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Hisato Takagi, MD, PhD, Masafumi Matsui, MD, Takuya Umemoto, MD, PhD

Mark I. Block, MD The Annals of Thoracic Surgery

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Late Consequences of a Much Earlier Decision

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve Diana Aicher, MD, Moritz Bewarder, Michael Kindermann, MD, Hashim Abdul-Khalique,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Myocardial, Inflammatory, and Stress Responses in Off-Pump Coronary Artery Bypass Graft Surgery With Thoracic Epidural Anesthesia Massimo Caputo, MD,

Presentation transcript:

Cell Saver for On-pump Coronary Operations Reduces Systemic Inflammatory Markers: A Randomized Trial Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W. Andersen, MD, DMSc, Klaus Bendtzen, MD, DMSc, Michael Tvede, MD, Daniel A. Steinbrüchel, MD, DMSc The Annals of Thoracic Surgery Volume 89, Issue 5, Pages 1511-1517 (May 2010) DOI: 10.1016/j.athoracsur.2010.02.003 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 The graph shows, only for the 15 cell saver patients before and after cell saving, the relative changes of certain inflammatory markers in the (A) suction blood and in the residual blood from the (B) cardiopulmonary bypass (CPB) circuit before retransfusion. Columns are median percentage changes with quartiles. All changes were statistically significant (p < 0.05) except for procalcitonin (PCT) in the CPB blood (p = 0.279). There was an increase in interleukin (IL)-8 in the CPB blood after cell saver processing (p = 0.031). (sTNF-RI and -RII = soluble tumor necrosis factor receptor I and II.) The Annals of Thoracic Surgery 2010 89, 1511-1517DOI: (10.1016/j.athoracsur.2010.02.003) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions